Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).
| Image |  |
|---|---|
| Description | scientific article published on 9 October 2014 |
| Author/s |
author: Felix Ratjen Claire Wainwright Isabelle Sermet-Gaudelus |
| Publication date | October 9, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |